Home » Newsletters » BioWorld Science

BioWorld Science

March 31, 2020

View Archived Issues

Butyrate affects regulatory B cells, rheumatoid arthritis

Lamin A/C's presence in nucleus, absence from membrane both problematic in progeria

New animal model more accurate for assessing nerve agent poisoning countermeasures

Screening opens in U.K. for first-in-human study of COVID-19 vaccine candidate ChAdOx1 nCoV-19

FDA approves Taltz for pediatric patients with plaque psoriasis

SMOC1 as a novel therapeutic target in atopic dermatitis

ISA-101 vaccine demonstrates promising efficacy in advanced cervical cancer

New serine-protein kinase ATM inhibitors disclosed by Suzhou Zanrong Pharma

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BTK inhibitors

Chengdu Origin Biotechnology discovers proteosome inhibitors

New melanocortin MC4 receptor agonists synthesized at Novo Nordisk

Roche identifies new HBV cccDNA inhibitors

Structural studies show similarities and differences in SARS, COVID-19 receptor binding

New Parkinson's disease model induced via dysregulation in dopamine sequestration

Researchers identify biomarkers for monitoring progression of colorectal cancer

HMPL-453 begins new phase II study in China for advanced malignant mesothelioma

Inovio reports phase II interim data on VGX-3100 in HPV-related vulvar dysplasia

Golden Biotech advances phase I/II study of antroquinonol for stage IV metastatic pancreatic cancer

Interim phase I data show confirmed responses with XMT-1536 in pretreated ovarian cancer and NSCLC

DNASE1L3 is a diagnostic marker of ankylosing spondylitis

European Commission approves Nubeqa for nonmetastatic castration-resistant prostate cancer

Otsuka studies OPC-214870 in subjects with history of photoparoxysmal response on EEG

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...